The Group's principal activity is developing, manufacturing and marketing non-invasive patient monitoring products that improve patient care. The Group's product Masimo Signal Extraction Technology or Masimo SET provides the capabilities of read-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Pulse oximetry is the non-invasive measurement of the oxygen saturation level of arterial blood, or the blood that delivers oxygen to the body's tissues, and pulse rate. Its products are distributed through direct sales force and certain distributors. The Group operates in the United States, Europe, Japan Middle East and Africa, Australia and Asia.
Alacra Alerts:
Receive alerts on the latest reports on Masimo Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
